Brain metastases: Presentation, evaluation, and management

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 2, 2000, Pages 120-127

  Chidel, Mark A ^b   Suh, John H ^a   Barnett, Gene H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID;

BRAIN METASTASIS; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; HUMAN; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0033953493     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.2.120     Document Type: Review

References (45)

1. Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastasis. Ann Neurol 1980; 7:529-541.
2. Posner JB. Management of brain metastasis. Rev Neurol (Paris), 1992; 148:477-487.
3. Wright DC, Delaney TF, Buckner JC. Treatment of metastatic cancer. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th edition. Philadelphia: Lippincott, 1993:2170-2186.
4. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1997; 49:8-31.
5. Hildebrand J. Lesions of the nervous system in cancer patients. Monograph series of the EORTC Vol. 5 New York: Raven Press, 1978.
6. Takakura K, Sano K, Hoho S, et al. Metastatic tumors of the central nervous system. Tokyo: Igaku-Shoin, 1982.
7. Galich JH, Sundaresan N. Metastatic brain tumors. In Wilkins RH, Rengachary SS, editors. Neurosurgery. New York: McGraw-Hill, 1985:597-610.
8. Posner JB. Diagnosis and treatment of metastasis to the brain. Clin Bull 1974; 4:47-57.
9. Graus F, Walker RW, Allen JC. Brain metastases in children. J Pediatr 1983; 103:558-561.
10. Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: Comparison of contrast enhanced MR with unenhanced MR and enhanced CT. AJNR: Am J Neuroradiol 1990; 11:785-791.
11. Nicolson GL, Dulski KM. Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 1986; 38:289-294.
12. Delattre JY, Krol G, Thaler HT, Posner JB. The distribution of brain metastases. Arch Neurol 1988; 45:741-744.
13. Hwang TL, Close TP, Grego JM, Brannon WL, Gonzales F. Predilection of brain metastasis in the gray and white matter junction and vascular border zones. Cancer 1996; 77:1551-1555.
14. Patchell RA. The treatment of brain metastasis. Cancer Invest 1996; 14:169-177.
15. Sorenson JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988; 6:1474-1480.
16. Hoskin PJ, Crow J, Ford HT. The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990; 19:111-115.
17. Posner JB. Clinical manifestations of brain metastases. In: Weiss L, Gilbert HA, Posner JB, editors. Brain metastasis. Boston: GK Hall, 1980:189-207.
18. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma: Autopsy study. Cancer 1983; 52:2349-2354.
19. Runge VM, Kirsch JE, Burke VJ, et al. High dose gadoteridol in MR imaging of intracranial neoplasms. J Magn Reson Imaging 1992; 2:9-18.
20. Reider-Groswasser I, Merimsky O, Karminsky N, Chaitchik S. Computed tomography features of cerebral spread of malignant melanoma. Am J Clin Oncol 1996; 19:49-53.
21. Akeson P, Larsson EM, Kristofferson DT, Jonsson E, Holtas S. Brain metastases: comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT, and non-contrast-enhanced MR imaging. Acta Radiologica 1995; 36:300-306.
22. Yuh WT, Fisher DJ, Runge VM, et al. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastasis. A J Neurorad 1994; 15:1037-1051.
23. Manzione JV, Poe LB, Kieffer SA. Intracranial neoplasms. In: Haaga JR, Lanzieri CF, Sartoris DJ, Zerhouni EA, editors. Computed Tomography and Magnetic Resonance Imaging of the Whole Body. 3rd edition. St. Louis: Mosby, 1994:170-238.
24. Markesbery WR, Brooks WH, Gupta GD, Young AB. Treatment for patients with cerebral metastases. Arch Neurol 1978; 35:754-756.
25. Ruderman NB, Hall TC. The use of corticosteroids in the palliative treatment of metastatic brain tumors. Cancer, 1965; 18:298-306.
26. Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irraciation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 1971; 111:334-336.
27. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastasis to the brain. N Engl J Med 1990; 322:494-500.
28. Flickinger JC, Kondziolka D, Lunsford D, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994; 28:797-802.
29. Alexander E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastasas. J Natl Cancer Inst 1995; 87:34-40.
30. Smalley SR, Laws ER, O'Fallon JR, Shaw EG, Schray MF. Resection for solitary brain metastasis. J Neurosurg 1992; 77:531-540.
31. Fernandez-Vicioso E, Suh JH, Kupelian PA, Sohn JW, Barnett GH. Analysis of prognostic factors for patients with solitary brain metastasis treated/by stereotactic radiosurgery. Radiat Oncol Invest 1997; 5:31-37.
32. Vecht CJ, Haaxma-Reiche H, Noordjik EM, et al. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33:583-590.
33. Joseph J Adler JR, Cox RS, Hancock SL. Linear accelerator based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 1996; 14:1085-1092.
34. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745-751
35. Ehrenkranz JR, Posner JB. Adrenocorticosteroid Hormones In: Weiss L, Gilbert HA, Posner JB, editors. Brain Metastasis. Boston: GK Hall, 1980:340-363.
36. Chang DB, Yang PC, Luh KT, Kuo SH, Hong RL, Lenri LN. Late survival of non-small cell lung cancer patients with brain metastases. Chest 1992; 101:1293-1297.
37. Cohen B, Strauss G, Lew R, Silver D, Recht L. Should prophylactic ant convulsants be administered to patients with newly diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988; 6:1621-1624.
38. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6:1-9.
39. Kramer S, Hendrickson F, Zelen M, Scholtz W. Therapeutic trial in the management of metastatic brain tumors by different time/dose fractionation scheme of radiation therapy. NCI Mono 1977; 46:213-221.
40. Kurtz JM, Gelber R, Brady LW, et al. The palliation of brain metastases in a favorable patient population: a randomized clinical tria . IJROBP 1981; 7:891-895.
41. Egawa S, Tukiyama I, Akine Y. Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 1986; 12:1621-1625.
42. Abner A. Prophylactic cranial irradiation in the treatment of small-cell carcinoma of the lung. Chest 1993; 103(4supp):445s-448s.
43. Rubenstein JH, Dosoretz DE, Katin MJ, et al. Low doses of prophylactic cranial irradiation effective in limited stage small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1995; 33:329-337.
44. Lee JS, Umsawasdi T, Barkley HT Jr, et al. Timing of elective brain irradiation: a critical factor for brain metastasis-free survival in small cell lung cancer. Int J Radiat Oncol Biol Phys 1987; 13:697-704.
45. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280:1485-1489.